Centrum Medyczne ENEL-MED S.A (ENE) Fair Value & Analysis
Healthcare · PL · Market cap 537M PLN
Fair value as of: Jun 24, 2026
Analysis
Centrum Medyczne ENEL-MED S.A (ENE) currently trades at 19.20 PLN, while our model-based Fair Value estimate is 10.03 PLN — implying the stock looks roughly 47.8% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Centrum Medyczne ENEL-MED S.A., together with its subsidiaries, operates hospitals in Poland, Austria, France, the United Kingdom, and internationally. It offers various medical services comprising pediatric specialist consultations, dentistry, orthopedic, infertility treatment, rehabilitation, psychological, imaging and diagnostics, laboratory diagnostics, and emergency care services. The company also provides vaccination services for adult and children. Centrum Medyczne ENEL-MED S.A. was founded in 1993 and is headquartered in Warsaw, Poland.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Centrum Medyczne ENEL-MED S.A (ENE) undervalued?
What is the fair value of ENE?
What is the quality score of ENE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.